Exhibiting at the World Drug Safety Congress, Amesterdam 2025

PharmaKnowl Consulting is proud to announce our participation as an exhibitor at the World Drug Safety Congress Europe 2025, taking place on October 7–8, 2025, at the RAI Amsterdam.

📍 Visit us at Booth 38

The World Drug Safety Congress is one of the most influential global gatherings for pharmacovigilance, drug safety, and risk management professionals. Each year, it brings together regulators, pharmaceutical leaders, biotech companies, and service providers to discuss the latest strategies, innovations, and technologies that ensure patient safety throughout the life cycle of medicines and medical products.

As Saudi Arabia’s leading SFDA-licensed regulatory consulting firm, PharmaKnowl is uniquely positioned to support global companies with their pharmacovigilance and drug safety obligations in the Middle East. Our team of former SFDA officials and regulatory experts offers comprehensive services tailored to meet both local and international compliance standards.

During the congress, we will be sharing insights and showcasing PharmaKnowl’s specialized solutions, including:

• Pharmacovigilance system setup & management for establishing compliant systems for product monitoring and risk mitigation.
• Signal detection & risk assessment for advanced methodologies to identify and manage potential safety concerns.
• Regulatory strategy & reporting, ensuring timely and accurate submissions in alignment with SFDA, EMA, and global requirements.
• Global–regional integration bridging international safety frameworks with Middle Eastern regulatory expectations.

👉 Schedule a meeting with our team at Booth 38 to learn how PharmaKnowl can help you achieve seamless regulatory compliance and robust drug safety outcomes in Saudi Arabia and the GCC.